ICD-10-CM Code for Right-Sided Triple-Negative Breast Cancer
The appropriate ICD-10-CM code for right-sided triple-negative breast cancer is C50.911 (Malignant neoplasm of unspecified site of right female breast) or a more specific code from the C50.x series if the exact quadrant or location within the right breast is known.
Understanding the Coding Structure
The ICD-10-CM coding system for breast cancer follows a hierarchical structure where:
- C50.x represents malignant neoplasm of breast
- The 5th digit specifies the anatomical location within the breast (nipple, central portion, upper-inner quadrant, lower-inner quadrant, upper-outer quadrant, lower-outer quadrant, axillary tail, or overlapping lesion)
- The 6th digit indicates laterality: 1 = right, 2 = left, 9 = unspecified
Specific Code Selection
If the exact location within the right breast is documented:
- C50.011 - Malignant neoplasm of nipple and areola, right female breast
- C50.111 - Malignant neoplasm of central portion of right female breast
- C50.211 - Malignant neoplasm of upper-inner quadrant of right female breast
- C50.311 - Malignant neoplasm of lower-inner quadrant of right female breast
- C50.411 - Malignant neoplasm of upper-outer quadrant of right female breast
- C50.511 - Malignant neoplasm of lower-outer quadrant of right female breast
- C50.611 - Malignant neoplasm of axillary tail of right female breast
- C50.811 - Malignant neoplasm of overlapping sites of right female breast
If the location is not specified:
- C50.911 - Malignant neoplasm of unspecified site of right female breast
Important Coding Considerations
The ICD-10-CM code does NOT capture the triple-negative status directly. Triple-negative breast cancer (TNBC) is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 overexpression 1, 2. This biological classification represents 10-20% of invasive breast cancers and carries distinct prognostic and therapeutic implications 3.
Additional Documentation Requirements:
While the primary diagnosis code captures the anatomical location and laterality, the triple-negative status should be documented separately through:
- Pathology reports showing ER-negative, PR-negative, HER2-negative status
- Clinical documentation of receptor status in the medical record
- Staging information using the AJCC TNM system 4
Clinical Context
TNBC is characterized by 1, 2:
- Higher FDG avidity on PET/CT imaging
- More aggressive biological behavior
- Higher risk of visceral metastases, particularly lung
- Peak recurrence risk within 3 years of diagnosis 3
- More common in younger, premenopausal women and women of African descent 3
The laterality (right-sided) is clinically relevant because it affects surgical planning, radiation therapy fields, and lymph node assessment patterns, though it does not significantly alter the biological behavior of TNBC itself.
Common Pitfalls to Avoid
- Do not use unspecified codes (C50.911) when specific anatomical location is documented - always code to the highest level of specificity available
- Do not confuse triple-negative status with the anatomical code - these are separate documentation elements
- Always verify the 6th digit for laterality - right = 1, left = 2, bilateral = 3
- For bilateral disease, assign separate codes for each side rather than using an unspecified code